相关实验视频
Updated: May 21, 2025

08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
7.8K
在亡中由MCL-1进行BAK封存的结构基础
Shagun Srivastava1, Giridhar Sekar2, Adedolapo Ojoawo3
1Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Molecular cell
|April 5, 2025
概括
该BCL-2家族蛋白质MCL-1通过结合BAK.抑制细胞亡. 目前的MCL-1抑制剂效率低下,需要开发针对这种癌症途径的改进药物.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 细胞亡对于组织稳定至关重要,其失调有助于癌症等疾病.
- 在BCL-2 (B细胞淋巴瘤2) 蛋白家族调节细胞亡,与效应蛋白 (BAK,BAX) 介导线粒体外膜通透.
- 幸存的BCL-2蛋白质,如MCL-1 (骨髓细胞白血病1),抑制效应蛋白,而仅BH3蛋白激活它们.
研究的目的:
- 从结构和生物化学上描述人类生存的MCL-1:BAK复合体.
- 评估现有的MCL-1抑制剂对这种复合物的疗效.
- 为设计用于癌症治疗的新型,更有效的MCL-1抑制剂提供信息.
主要方法:
- 综合结构生物学 (晶体学),生化分析和药理学研究.
- 使用BCL-2球状核心域对MCL-1:BAK复合物的表征.
- 在存在MCL-1:BAK复合物的情况下,通过MCL-1抑制剂诱导亡的评估.
主要成果:
- 揭示了BAK BH3与MCL-1疏水槽结合的正规相互作用.
- 在核心交互界面之外,确定了BAK的无序和动态区域.
- 证明当前的MCL-1抑制剂在中和MCL-1:BAK复合物方面效率低下,需要高度来诱导亡.
结论:
- 该MCL-1:BAK复杂结构提供了对亡调节的见解.
- 现有的MCL-1抑制剂对目标复合体的疗效有限.
- 开发卓越的临床候选MCL-1抑制剂以有效向癌症至关重要.
关键词:
在BCL-2对手杀手BAK中,BCL-2对手杀手是BAK.这是一种BCL-2家族蛋白质.类似BCL-2的蛋白质11 BIM BIMBH3模仿的是 BH3 的模仿.与BH3相互作用的域死亡激动剂BID.只有BH3的启动器这是一种MCL-1抑制剂.核磁共振光谱法 (NMR) 是一种光谱法.甲基-12-米里-13-乙酸盐诱导的蛋白质1 NOXA.在X射线晶体学.灭症 (apoptosis) 是一种死亡的过程.抗亡的耐药性 抗亡的耐药性冷电子显微镜的使用方法直接的BAK激活方式诱导性髓性白血病细胞分化蛋白 MCL-1线粒体外膜通透性MOMPMOMP的外膜通透性模式II MCL-1:BAK 绑定方式模式II中和方式的中和.产生的死亡效应因子.普罗斯维尔维尔的监护人相关概念视频
The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
The Extrinsic Apoptotic Pathway
5.7K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.7K
Caspases
11.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
11.7K
Phagocytosis of Apoptotic Cells
3.3K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.3K
Apoptosis
10.4K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
10.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K

